InVivo Therapeutics Holdings Corporation
InVivo Therapeutics Holdings Corporation (NVIV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NVIV · as of Jun 9, 2026
Key Statistics
Explore InVivo Therapeutics Holdings Corporation Data
nviv stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
Competitors & Peers
nviv competitorsNVIV
AXDX
BLCM
CWBR
CYTO
HTGMQStock Performance
Full HistoryAbout InVivo Therapeutics Holdings Corporation
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm, actively involved in research and clinical development. The company specializes in creating and bringing to market innovati…
what is invivo therapeutics holdings corporation · nviv stock overview · invivo therapeutics holdings corporation company profile · who is invivo therapeutics holdings corporation ceo · nviv NASDAQ · invivo therapeutics holdings corporation headquarters · invivo therapeutics holdings corporation business segments
About Stock Overview & Key Data
InVivo Therapeutics Holdings Corporation (NVIV) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 15, 2010. As of the latest trading session, NVIV stock price is $0.32, with a market capitalization of $995,918. The stock has returned -67.93% over the past 12 months and -59.38% year-to-date.
According to 3 Wall Street analysts, the consensus rating for InVivo Therapeutics Holdings Corporation stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, InVivo Therapeutics Holdings Corporation reported revenue of — and net income of -$10.2M. For detailed data — including InVivo Therapeutics Holdings Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, InVivo Therapeutics Holdings Corporation (NVIV) stock price is $0.32. The stock is traded on NASDAQ under the ticker symbol NVIV. The 52-week range is $0.22 – $2.40.